475 related articles for article (PubMed ID: 12844412)
1. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
Zhang Z; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
[TBL] [Abstract][Full Text] [Related]
2. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
[TBL] [Abstract][Full Text] [Related]
3. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
[TBL] [Abstract][Full Text] [Related]
5. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of the expression of Fas/Fasl in bone marrow CD34+ cells in myelodysplastic syndromes: relation to disease progression.
Ribeiro E; Lima CS; Metze K; Lorand-Metze I
Leuk Lymphoma; 2004 Feb; 45(2):309-13. PubMed ID: 15101716
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
Berger G; Hunault-Berger M; Rachieru P; Fontenay-Roupie M; Baranger L; Ifrah N; Zandecki M
Hematol J; 2001; 2(2):87-96. PubMed ID: 11424000
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
Boudard D; Vasselon C; Berthéas MF; Jaubert J; Mounier C; Reynaud J; Viallet A; Chautard S; Guyotat D; Campos L
Am J Hematol; 2002 Jun; 70(2):115-25. PubMed ID: 12111784
[TBL] [Abstract][Full Text] [Related]
10. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
Gersuk GM; Beckham C; Loken MR; Kiener P; Anderson JE; Farrand A; Troutt AB; Ledbetter JA; Deeg HJ
Br J Haematol; 1998 Oct; 103(1):176-88. PubMed ID: 9792306
[TBL] [Abstract][Full Text] [Related]
11. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
Parker JE; Fishlock KL; Mijovic A; Czepulkowski B; Pagliuca A; Mufti GJ
Br J Haematol; 1998 Dec; 103(4):1075-82. PubMed ID: 9886323
[TBL] [Abstract][Full Text] [Related]
12. Absolute number of circulating CD34+ cells is abnormally low in refractory anemias and extremely high in RAEB and RAEB-t; novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytometry.
Fuchigami K; Mori H; Matsuo T; Iwanaga M; Nagai K; Kuriyama K; Tomonaga M
Leuk Res; 2000 Feb; 24(2):163-74. PubMed ID: 10654453
[TBL] [Abstract][Full Text] [Related]
13. [Four-color flow cytometric immunophenotypic features of blasts in myelodysplastic syndromes].
Wu YJ; Li JY; Qiu HR; Xiao B; Zhang JF; Song JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):50-3. PubMed ID: 16584591
[TBL] [Abstract][Full Text] [Related]
14. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
15. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
[TBL] [Abstract][Full Text] [Related]
16. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
[TBL] [Abstract][Full Text] [Related]
17. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
18. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].
Xu HZ; Li A; Yu Y; Li JF; Liu X; Wang XH; Wang X; Xu GL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1308-11. PubMed ID: 19099633
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival.
Gupta P; Niehans GA; LeRoy SC; Gupta K; Morrison VA; Schultz C; Knapp DJ; Kratzke RA
Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059
[TBL] [Abstract][Full Text] [Related]
20. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
